- Home
- ARWR vs NVG Comparison
ARWR vs NVG Comparison
Compare ARWR & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | NVG |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 2.7B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | NVG |
|---|---|---|
| Price | $64.39 | $12.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $63.70 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 568.8K |
| Earning Date | 11-25-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $829,448,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23258.15 | N/A |
| 52 Week Low | $9.57 | $9.68 |
| 52 Week High | $72.36 | $12.21 |
Technical Indicators
Market Signals| Indicator | ARWR | NVG |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 43.76 |
| Support Level | $59.51 | $12.52 |
| Resistance Level | $72.36 | $12.79 |
| Average True Range (ATR) | 4.67 | 0.08 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 59.17 | 9.26 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.